RespirTech

Executive Summary

RespirTech is a privately held US medical device and services company headquartered in St. Paul, Minnesota, specializing in respiratory care. Since its founding in 2004, the company has established itself as a distributor of advanced airway clearance devices, including the Philips InCourage vest therapy system and the Philips Respironics CoughAssist T70. These products are used to manage chronic lung conditions such as cystic fibrosis, bronchiectasis, and neuromuscular disorders. Beyond distribution, RespirTech provides comprehensive support services, including clinical guidance and reimbursement assistance, to patients, caregivers, and healthcare providers. The company operates at the intersection of respiratory care and digital health, though its current offerings are primarily device-focused. With a lean operational model and a focus on patient-centric solutions, RespirTech serves a niche but essential segment of the respiratory care market. However, as a distributor rather than an original device manufacturer, the company's growth is closely tied to the success and innovation of its partner, Philips. The company's private status and limited public disclosure constrain visibility into financials and pipeline, but its established relationships and reputation in the respiratory community provide a stable foundation.

Upcoming Catalysts (preview)

• Q3 2026Expansion of Reimbursement Coverage for Airway Clearance Devices70% success
• Q4 2026New Product Launch from Philips (e.g., Next-Generation InCourage Vest)60% success
• Q1 2027Strategic Partnership or Acquisition to Broaden Digital Health Capabilities40% success